Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1-3) arabinofuranosyltransferase by Birch, Helen et al.
 
 
University of Birmingham
Biosynthesis of mycobacterial arabinogalactan:
identification of a novel alpha(1-3)
arabinofuranosyltransferase
Birch, Helen; Alderwick, Luke; Bhatt, Apoorva; Rittmann, D; Krumbach, K; Singh, Albel; Bai,
Y; Lowary, TL; Eggeling, L; Besra, Gurdyal
DOI:
10.1111/j.1365-2958.2008.06354.x
Citation for published version (Harvard):
Birch, H, Alderwick, L, Bhatt, A, Rittmann, D, Krumbach, K, Singh, A, Bai, Y, Lowary, TL, Eggeling, L & Besra, G
2008, 'Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1-3)
arabinofuranosyltransferase', Molecular Microbiology, vol. 69, no. 5, pp. 1191-206.
https://doi.org/10.1111/j.1365-2958.2008.06354.x
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Biosynthesis of mycobacterial arabinogalactan: identiﬁcation
of a novel a(1,3) arabinofuranosyltransferase
Helen L. Birch,1† Luke J. Alderwick,1†
Apoorva Bhatt,1 Doris Rittmann,2 Karin Krumbach,2
Albel Singh,1 Yu Bai,3 Todd L. Lowary,3
Lothar Eggeling2 and Gurdyal S. Besra1*
1School of Biosciences, University of Birmingham,
Edgbaston, Birmingham B15 2TT, UK.
2Institute for Biotechnology 1, Research Centre Juelich,
D-52425 Juelich, Germany.
3Alberta Ingenuity Centre for Carbohydrate Science and
Department of Chemistry, University of Alberta, AB,
Canada T6G 2G2.
Summary
The cell wall mycolyl-arabinogalactan–peptidoglycan
complex is essential in mycobacterial species, such
as Mycobacterium tuberculosis and is the target of
several antitubercular drugs. For instance, ethambu-
tol targets arabinogalactan biosynthesis through inhi-
bition of the arabinofuranosyltransferases Mt-EmbA
and Mt-EmbB. A bioinformatics approach identified
putative integral membrane proteins, MSMEG2785 in
Mycobacterium smegmatis, Rv2673 in Mycobacte-
rium tuberculosis and NCgl1822 in Corynebacterium
glutamicum, with 10 predicted transmembrane
domains and a glycosyltransferase motif (DDX),
features that are common to the GT-C superfamily
of glycosyltransferases. Deletion of M. smegmatis
MSMEG2785 resulted in altered growth and glycosyl
linkage analysis revealed the absence of AG a(1,3)-
linked arabinofuranosyl (Araf) residues. Complemen-
tation of the M. smegmatis deletion mutant was fully
restored to a wild-type phenotype by MSMEG2785
and Rv2673, and as a result, we have now termed
this previously uncharacterized open reading frame,
arabinofuranosyltransferase C (aftC). Enzyme as-
says using the sugar donor b-D-arabinofuranosyl-1-
monophosphoryl-decaprenol (DPA) and a newly syn-
thesized linear a(1,5)-linked Ara5 neoglycolipid
acceptor together with chemical identification of
products formed, clearly identified AftC as a branch-
ing a(1,3) arabinofuranosyltransferase. This newly
discovered glycosyltransferase sheds further light on
the complexities of Mycobacterium cell wall biosyn-
thesis, such as in M. tuberculosis and related species
and represents a potential new drug target.
Introduction
Tuberculosis (TB) affects a third of the world population
and causes 1.8 million fatalities annually (Dye, 2006). The
spread of TB has been facilitated in recent years due to the
susceptibility of HIV-infected individuals to Mycobacterium
tuberculosis, the aetiological agent of TB (Paolo and
Nosanchuk, 2004). The problem has also been com-
pounded by the emergence of multidrug-resistant TB
(MDR-TB) (Kaye and Frieden, 1996) and extensively drug-
resistant (XDR)-TB strains (Shah et al., 2007). M. tubercu-
losis and other mycobacteria have a distinct cell wall which
has a lipid-rich outer layer that is highly impermeable
(Minnikin, 1982). One of the major components of this
outer envelope are mycolic acids, long-chain a-alkyl,
b-hydroxy fatty acids that are essential for bacterial survival
(Vilcheze et al., 2000; Portevin et al., 2004; Bhatt et al.,
2005; Parish et al., 2007). These are found either esterified
to the non-reducing termini of arabinogalactan (AG), or are
present as trehalose esters, such as trehalose dimycolate
(TDM) (Brennan and Nikaido, 1995; Dover et al., 2004).
A common feature of members of the Corynebacteria-
neae is that they all possess this unusual cell wall archi-
tecture (McNeil et al., 1990; 1991; Besra et al., 1995).
Apart from mycolic acids, the cell wall is dominated by a
second macromolecule, an essential heteropolysaccha-
ride termed AG, which is linked to both mycolic acids and
peptidoglycan, forming the mycolyl-arabinogalactan–
peptidoglycan (mAGP) complex (Daffé et al., 1990; McNeil
et al., 1990; 1991; Besra et al., 1995). The formation of the
arabinan domain (a1→5, a1→3 and b1→2 glycosyl link-
ages) of AG results from the subsequent addition of ara-
binofuranose (Araf) residues by a set of unique
arabinofuranosyltransferases including, the Emb proteins
of which three paralogues exist in Mycobacterium
avium (Belanger et al., 1996) and M. tuberculosis (Telenti
et al., 1997),AftA (Alderwick et al., 2006a) andAftB (Seidel
Accepted 17 June, 2008. *For correspondence. E-mail g.besra@
bham.ac.uk; Tel. (+44) 121 4158 125; Fax (+44) 121 4145 925.
†These authors contributed equally to the work.
Re-use of this article is permitted in accordance with the Creative
Commons Deed, Attribution 2.5, which does not permit commercial
exploitation.
 OnlineOpen: This article is available free online at www.blackwell-synergy.com
Molecular Microbiology (2008) 69(5), 1191–1206  doi:10.1111/j.1365-2958.2008.06354.x
First published online 15 July 2008
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd
et al., 2007a). The lipid linked sugar donor b-D-
arabinofuranosyl-1-monophosphoryldecaprenol (DPA;
Wolucka et al., 1994; Lee et al., 1995; 1997) serves as the
substrate molecule for these complex membrane-bound
glycosyltransferases.
The antituberculosis drug ethambutol (EMB) was shown
to specifically inhibit AG biosynthesis (Takayama and
Kilburn, 1989). The precise molecular target of EMB occu-
pies the embCAB locus in M. tuberculosis (Telenti et al.,
1997). To further define the role of EmbCAB proteins in cell
wall arabinan biosynthesis, embA, embB and embC were
individually inactivated in Mycobacterium smegmatis
(Escuyer et al., 2001; Zhang et al., 2003).All three mutants
were viable; however, the non-reducing terminal Ara6 motif
which is the template for mycolylation in AG (McNeil et al.,
1991) was altered in both the M. smegmatis (Ms)-embA
and Ms-embB mutants (Escuyer et al., 2001), while
Ms-embC was shown to be involved in the formation of the
arabinan domains of lipoarabinomannan (LAM; Zhang
et al., 2003). Attempts to obtain deletion mutants of embA
(Amin et al., 2008) and embB in M. tuberculosis and
embAB in M. smegmatis have proved unsuccessful (G.S.
Besra, unpubl. results). In contrast, deletion of the single
C. glutamicum (Cg)-emb orthologue and chemical analy-
sis of the cell wall revealed a novel truncated AG structure
possessing only terminal (t)-Araf residues with a corre-
sponding loss of cell wall-bound mycolic acids (Alderwick
et al., 2005). The presence of a novel enzyme responsible
for ‘priming’ the galactan domain for further elaboration by
Emb proteins led to the identification of AftA (Alderwick
et al., 2006a). Recently, a retaining GT-C enzyme was
identified, now termed AftB, which is responsible for the
attachment of terminal b(1→2) Araf residues, and marks
the ‘end-point’ for AG arabinan biosynthesis (Fig. 1) before
decoration with mycolic acids (Seidel et al., 2007a).
It is clear that additional arabinofuranosyltransferases
involved in AG and LAM biosynthesis still remain to be
identified. Indeed, Liu and Mushegian (2003) identified 15
members of the GT-C superfamily residing in M. tubercu-
losis, representing candidates involved in the biosynthesis
of cell wall-related glycans and lipoglycans (Liu and Mush-
egian, 2003). We have continued our earlier studies (Alder-
wick et al., 2006a,b; Seidel et al., 2007a) to identify genes
required for the biosynthesis of the core structural ele-
ments of the mAGP complex by studying mutants of
M. smegmatis and the orthologous genes and enzymes of
M. tuberculosis and Corynebacterium glutamicum. Herein,
we present MSMEG2785, Rv2673 and NCgl1822 as a new
distinct arabinofuranosyltransferase of the GT-C super-
family, which is responsible for the transfer of Araf residues
from DPA to the arabinan domain to form a(1→3)-linked
Araf residues, which result in the branched arabinan
domain distal to the non-reducing terminal Ara6 motif char-
acteristic of mycobacterial AG.
Results
Genome comparison of the Rv2673 locus
The arabinofuranosyltransferases EmbA, EmbB and
EmbC are vital for M. tuberculosis and represent a target
for the established drug EMB (Mikusova et al., 1995;
Belanger et al., 1996; Telenti et al., 1997). Structural con-
siderations of these proteins and a search for new drug
targets resolved that more than 16 related proteins are
Fig. 1. Biosynthetic pathway leading to arabinan formation in
M. tuberculosis AG.
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present in M. tuberculosis, possibly also acting as glyco-
syltransferases (Liu and Mushegian, 2003). In our sys-
tematic analysis of GT-C glycosyltransferases, focusing
on those present in M. tuberculosis and C. glutamicum,
we have previously identified the arabinofuranosyltrans-
ferases AftA (Alderwick et al., 2006a) and AftB (Seidel
et al., 2007a), as well as several a-mannosyltransferases
(Mishra et al., 2007; 2008). Each of these glycosyltrans-
ferases plays a specific yet decisive role in cell wall bio-
synthesis and assembly. In silico analysis of one of the
putative glycosyltransferases of M. tuberculosis, Rv2673,
highlighted that orthologues are present in a range of
species belonging to the suborder Corynebacterianeae,
including the families Mycobacteriaceae, Corynebacteria-
cea and Nocardiaceae (Fig. 2A). Furthermore, the orga-
nization of the gene locus is largely retained. The adjacent
genes are largely of unknown function. RibD encodes a
bifunctional deaminase–reductase domain, followed by a
gene product containing a hydrolase domain, which is
however, absent in Corynebacterium, and downstream of
Rv2673 a gene of unknown function is present. The wide
distribution of Rv2673, its syntenic organization, and the
fact that it is retained even in M. leprae, strongly indicates
a fundamental function of its product. According to our
experimental analysis (see below) we annotated this gene
arabinofuranosyltransferase C (aftC).
AftC of M. tuberculosis is 433 amino acid residues long.
It is a hydrophobic protein and is predicted to possess 10
transmembrane-spanning segments (Fig. 2B). However,
in contrast to AftA, AftB or EmbC, it is characterized by the
absence of a periplasmic carboxyterminal extension. The
amino acid sequence among the Corynebacterianeae is
very well conserved, and there are 43% identical residues
shared by the M. tuberculosis and C. glutamicum proteins.
The degree of conservation is particularly high in the loop
regions, for instance between helixes 1 and 2, 3 and 4, or
6 and 7 (Fig. 2B). The fully conserved aspartyl (D) and
glutamyl (E) residues, which we propose to be involved in
catalysis or substrate binding, are located in the first
extended loop region (Liu and Mushegian, 2003), as we
have demonstrated for similarly located aspartyl (D) resi-
dues of Cg-Emb and AftB (Seidel et al., 2007a,b). Interest-
ingly, the long transmembrane helix 8 is well conserved
and it is within this region that there is a strong identity to a
membrane protein of Vibrio parahaemolyticus (CpsG).
Furthermore, this gene is located in a gene cluster involved
in the biosynthesis of a capsular polysaccharide within this
pathogen (Guvener and McCarter, 2003).
Construction and growth of mutants
In order to delete aftC and study for possible conse-
quences we generated a null mutant of M. smegmatis
mc2155 MSMEG2785 (orthologue of Rv2673) using
specialized transduction (Fig. 3A). In contrast to
our C. glutamicum studies (see below) growth of
M. smegmatisDaftC in comparison to M. smegmatis was
poor in liquid medium (Fig. 3B) and sensitive to the addition
of Tween-80 on agar plates (> 0.005%). Complementation
Fig. 2. Comparison of the aftC locus within the
Corynebacterianeae.
A. The locus in the bacteria analysed consists of aftC which in
M. tuberculosis has the locus tag Rv2673 and in C. glutamicum
NCgl1822. The genomic region displayed encompasses 7 kb, and
orthologous genes are highlighted accordingly. M. marinum,
Mycobacterium marinum; M. av ssp. par., Mycobacterium avium
ssp. paratuberculosis; C. efficiens, Corynebacterium efficiens;
C. jeikeium, Corynebacterium jeikeium; Nocardia farcina, Nocardia
farcina IFM 10 152; Rhodococcus, Rhodococcus sp. strain RHA1.
B. AftC is a hydrophobic protein predicted to span the membrane
10 times and the transmembrane helices are numbered
accordingly. The lower part of the figure shows the degree of
conservation of the orthologues given in A as analysed by the
DIALIGN method (Brudno et al., 2003). Also shown is the
approximate position of the fully conserved aspartyl (D) and
glutamyl (E) residues.
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of M. smegmatisDaftC with either pMV261-Ms-aftC or
pMV261-M. tuberculosis (Mt)-aftC restored the mutant to a
wild-type phenotype (Fig. 3B). On solid media M. smeg-
matisDaftC had a smooth and glossy appearance in com-
parison to the typical crenulated colony morphology found
for wild-type M. smegmatis (Fig. 3C) and failed to stain as
‘acid-fast’ positive (data not shown). In addition, suscepti-
bility of M. smegmatisDaftC to EMB and the hydrophobic
antibiotics rifampicin and chloramphenicol was enhanced
(minimal inhibitory concentration of 2, 100 and 10 mg ml-1
for wild-type M. smegmatis in comparison to 0.4, 4 and
5 mg ml-1 for M. smegmatisDaftC respectively), indicating
increased permeability and that M. smegmatisDaftC had
an altered cell wall. To study the function of the corynebac-
terial AftC the non-replicative plasmid pK19mobsacBDaftC
was constructed. This was used to transform
C. glutamicum to kanamycin resistance, indicating integra-
tion in its chromosome (Fig. S1A). Loss of vector was
obtained by selection for sucrose-resistance yielding
clones with aftC deleted. A PCR analysis with primer pairs
P5 and P6 resulted in the expected fragment of 2160 bp for
the wild-type and of 1065 bp for the deletion mutant, which
was termed C. glutamicumDaftC. Colonies of this mutant
were more erose compared with the usual glossy appear-
ance of the wild-type colony (data not shown). In contrast to
M. smegmatisDaftC the growth of the C. glutamicumDaftC
mutant on the salt medium CGXII possessed only a slightly
reduced growth rate of 0.32 h-1, whereas, that of the wild-
type C. glutamicum was 0.39-1 h (Fig. S1B).
mAGP analyses from M. smegmatis,
M. smegmatisDaftC, M. smegmatisDaftC
pMV261-Ms-aftC, M. smegmatisDaftC pMV261-Mt-aftC,
C. glutamicum and C. glutamicumDaftC
To study the function of mycobacterial aftC deletion, defat-
ted cells were analysed qualitatively for AG esterified
mycolic acids and cell wall-associated lipids from an
equivalent starting amount of biomass for each strain due
to differences in growth rate (Fig. 3B). As expected,
M. smegmatis exhibited a typical profile of cell wall-bound
a, a′ and epoxy-mycolic acid methyl esters (MAMEs),
whereas, these products were drastically reduced in
M. smegmatisDaftC (Fig. 4A). In addition, complementa-
tion of M. smegmatisDaftC with either pMV261-Ms-aftC or
pMV261-Mt-aftC (Fig. 4A), led to the restoration of normal
‘levels’ of cell wall-bound mycolic acids. Analysis of cell
wall-associated lipids in several independent experiments
highlighted an apparent increase in TDM for the aftC
deletion mutant. This was confirmed quantitatively
through [14C]acetate labelling of cultures and equal
loading of radioactivity of extractable free lipids from
M. smegmatis, M. smegmatisDaftC and the comple-
mented M. smegmatisDaftC strain using plasmids
pMV261-Ms-aftC and pMV261-Mt-aftC (Fig. 4B). Typi-
cally, wild-type M. smegmatis synthesized 5250 cpm,
whereas M. smegmatisDaftC afforded 14 676 cpm of
TDM after equivalent loading of radioactivity and quanti-
tative analysis by phosphorimaging. Complementation of
M. smegmatisDaftC with either pMV261-Ms-aftC or
pMV261-Mt-aftC restored the phenotype of the deletion
mutant back to that of wild-type M. smegmatis (Fig. 4B).
These results demonstrated that Ms-aftC and Mt-aftC are
involved in a key aspect of arabinan biosynthesis,
whereby deletion substantially perturbs tethering of
mycolic acids to AG, which results in an increase in TDM
production.
The cell wall core (mAGP) was prepared from
M. smegmatis and M. smegmatisDaftC as described
(Daffé et al., 1990; Besra et al., 1995; Alderwick et al.,
2005) and the ratio of Ara to Gal in mAGP determined by
gas chromatography (GC) analysis of alditol acetates
(Daffé et al., 1990; Besra et al., 1995; Escuyer et al.,
2001; Alderwick et al., 2005) (Fig. 5). The glycosyl com-
position was calculated based on a single rhamnosyl
(Rha) residue per AG chain (McNeil et al., 1990). The
glycosyl compositional analysis revealed a relative molar
ratio of Rha : Ara : Gal of 1:71:31 and an Ara : Gal ratio of
2.3:1, which is in accord with previous data (Escuyer
et al., 2001). The M. smegmatisDaftC mutant yielded AG
with a significant reduction in Ara content concomitant
with a relative increase in the amount of Gal. The
M. smegmatisDaftC yielded an AG with an Rha : Ara : Gal
ratio of 1:22:56 and an Ara : Gal ratio of 0.4:1. Comple-
mentation of M. smegmatisDaftC with either pMV261-Ms-
aftC or pMV261-Mt-aftC, restored the Rha : Ara : Gal ratio
to that of wild-type M. smegmatis. Gas chromatography
mass spectrometry (GC/MS) analysis of per-O-
Fig. 3. Generation of a MSMEG2785 null mutant.
A. A map of the MSMEG2785 region in the parental M. smegmatis strain and its corresponding region in the DMSMEG2785 mutant. res, gd
resolvase site; hyg, hygromycin resistance gene from Streptomyces hygroscopicus; sacB, sucrose counter-selectable gene from Bacillus
subtilis. Digoxigenin-labelled probes were derived from ~1 kb upstream and downstream flanking sequences that were used to construct the
knockout plasmid, and are indicated by thick lines with square ends. SacI-digested bands expected in a Southern blot are indicated in roman
numerals with sizes in brackets. The inset shows the Southern blot of SacI-digested genomic DNA from the two strains with expected bands
indicated by arrows.
B. Growth of wild-type M. smegmatis (), M. smegmatisDaftC (), M. smegmatisDaftC pMV261-Ms-aftC () and M. smegmatisDaftC
pMV261-Mt-aftC () in TSB medium.
C. Colony morphology of wild-type M. smegmatis and M. smegmatisDaftC on TSB-agar plates. Black bar represents 1 mm.
Identification of a novel arabinofuranosyltransferase 1195
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 1191–1206
methylated alditol acetate derivatives prepared from
M. smegmatis and M. smegmatisDaftC indicated the
complete absence of 3,5-Araf branching residues and a
significant reduction in t-Araf, 2-Araf and 5-Araf-linkages
(Fig. 6). Complementation of M. smegmatisDaftC with
either plasmid encoding Ms-aftC or Mt-aftC restored the
glycosyl linkage profile to that of wild-type M. smegmatis
(Fig. 6). These results demonstrate that MSMEG2785
and Rv2673 are functionally equivalent and are involved
in the synthesis of 3,5-Araf branching residues. Interest-
ingly, LAM preparations from M. smegmatisDaftC were
truncated in size on SDS-PAGE analysis to ‘full-size’ LAM
from wild-type M. smegmatis. Further purification and
detailed chemical analyses of LAM from the aftC mutant
strain are currently being undertaken and will be reported
separately (H.L. Birch, unpubl. results).
In contrast to the mycolic acid studies performed with the
mycobacterial aftC deletion mutant, C. glutamicumDaftC
cells were analysed quantitatively for AG esterified coryne-
mycolic acids due to similar growth rates between strains
(Fig. S1B). Wild-type C. glutamicum exhibited the known
profile of corynomycolic acid methyl esters (CMAMEs,
35 345 cpm; Fig. S2), whereas, cell wall-bound CMAMEs
were significantly reduced in C. glutamicumDaftC
(8023 cpm). The above data were reassuring as the
qualitative (M. smegmatisDaftC) and quantitative
(C. glutamicumDaftC) analyses were comparable in
terms of a reduction in cell wall-bound mycolic acids
(Fig. 4A and Fig. S2). Importantly, these results have also
shown that Cg-aftC is involved in a key aspect of arabinan
biosynthesis, whereby deletion perturbs tethering of
corynomycolic acids to AG. The GC/MS profiles of per-
O-methylated alditol acetate derivatives of C. glutamicum
and C. glutamicumDaftC are shown in Fig. S3 with
C. glutamicumDaftC also clearly devoid of 3,5-Araf
branching residues.
In vitro arabinofuranosyltransferase activity with extracts
of M. smegmatis, M. smegmatisDaftC and
complemented strains
Initial attempts to develop an in vitro assay using either
purified recombinant expressed AftC or E. coli membranes
expressing aftC, have thus far proved unsuccess-
ful, probably due to the hydrophobic nature of the
protein. In an alternative approach, we assessed the
capacity of membrane preparations from M. smegmatis,
M. smegmatisDaftC and M. smegmatisDaftC comple-
Fig. 4. Analysis of cell wall-associated lipids and bound MAMEs
from M. smegmatis, M. smegmatisDaftC, M. smegmatisDaftC
pMV261-Ms-aftC and M. smegmatisDaftC pMV261-Mt-aftC.
A. Analysis of cell wall-bound MAMEs from M. smegmatis,
M. smegmatisDaftC, M. smegmatisDaftC pMV261-Ms-aftC and
M. smegmatisDaftC pMV261-Mt-aftC. The bound mycolic acids
from an equivalent amount of freeze-dried cells (100 mg), which
were initially de-lipidated using two consecutive extractions of
CHCl3/CH3OH/H2O (10/10/3; v/v/v) at 50°C for 4 h, were released
by the addition of tetra-butylammonium hydroxide at 100°C
overnight, and methylated as described in the Experimental
procedures. An equivalent aliquot from each strain was subjected
to TLC using silica gel plates (5735 silica gel 60F254, Merck), and
developed in petroleum ether/acetone (95:5, v/v) and charred to
reveal MAMEs and compared with known standards (Gande et al.,
2004).
B. Quantitative analysis of extractable [14C]-lipids from
M. smegmatis, M. smegmatisDaftC, M. smegmatisDaftC
pMV261-Ms-aftC and M. smegmatisDaftC pMV261-Mt-aftC. Lipids
were extracted from cells by a series of organic washes as
described in Experimental procedures (Seidel et al., 2007a). An
equivalent aliquot (50 000 cpm) from each strain was subjected to
TLC using silica gel plates (5725 silica gel 60F254, Merck)
developed in CHCl3/CH3OH/NH4OH (80:20:2, v/v/v) and quantified
using phosphorimaging and compared with known standards
(Mikusova et al., 1995) after exposure to Kodak X-Omat film for
24 h.
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mented with pMV261-Mt-aftC to catalyse arabinofurano-
syltransferase activity in the presence of exogenous
synthetic acceptors (Lee et al., 1997; Seidel et al., 2007a).
We first assessed whether M. smegmatisDaftC was defi-
cient in a(1→5) and b(1→2) arabinofuranosyltransferase
activity using an a-D-Araf-(1→5)-a-D-Araf-O-(CH2)7CH3
(Ara2) synthetic acceptor (Lee et al., 1997) and DP[14C]A
as a sugar donor based on an established assay format for
determining a(1→5) and b(1→2) arabinofuranosyltrans-
ferase activities (Lee et al., 1998). TLC/autoradiographic
analysis of the products which were only synthesized in the
presence of Ara2, when assayed with M. smegmatis mem-
branes resulted in the formation of two products (A and B)
(Fig. 7Aand B). The enzymatic synthesis of productsAand
B are consistent with our previous studies using mycobac-
terial (Lee et al., 1997) and corynebacterial (Seidel et al.,
2007a) membrane preparations resulting in trisaccharide
products as a result of a(1→5) and b(1→2) Araf linkages to
the Ara2 acceptor (Fig. 7A). Addition of EMB in several
experiments, even at high concentrations of up to
1 mg ml-1 to the reaction mixture, resulted in a decrease in
only the in vitro synthesized a-D-[14C]Araf-(1→5)-a-D-Araf-
(1→5)-a-D-Araf-O-(CH2)7CH3 product A (Fig. 7A and B).
Assays performed with membranes from M. smegmatis-
DaftC and the pMV261-Mt-aftC complemented strain using
the Ara2 synthetic acceptor gave a similar profile to that of
wild-type M. smegmatis (Fig. 7B). The data clearly show
that the M. smegmatisDaftC strain possesses comparable
levels of EMB-sensitive a(1→5) and EMB-resistant
b(1→2) arabinofuranosyltransferase activity.
The lack of a(1→3) arabinofuranosyltransferase activity
in the previously reported Ara2 and a-D-Araf-(1→5)-a-D-
Araf-(1→5)-a-D-Araf-O-(CH2)7CH3 (Ara3) acceptor-based
assays (Lee et al., 1997) required the development
of an arabinofuranosyltransferase assay using the
Ara-extended synthetic acceptor a-D-Araf-(1→5)-a-D-
Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-O-
(CH2)8NH2 (Ara5) (Supplementary experimental and
Fig. S4) and DP[14C]A as a sugar donor (Lee et al., 1998).
TLC/autoradiographic analysis of the products which are
only synthesized in the presence of Ara5, when assayed
with M. smegmatis membranes resulted in the formation
of a single product X (Fig. 8A) through the transfer of a
single [14C]Araf residue, with a retardation factor (Rf) con-
sistent with a synthetic Ara6 acceptor (Appelmelk et al.,
2008) standard (Fig. 8B). In addition, the synthesis of
product X in overexpression studies was enhanced. Con-
sistently from two independent membrane preparations
and assays performed in triplicate from M. smegmatis
pMV261-Mt-aftC produced product X (6453 cpm) in com-
parison to membranes from wild-type M. smegmatis
(4289 cpm) in the above assays, demonstrating that AftC
was functionally involved in the synthesis of product X.
The inclusion of EMB in several experiments, even at high
concentrations of up to 1 mg ml-1 to the reaction mixture
did not inhibit the synthesis of this in vitro synthesized
[14C]Araf-Ara5 (Fig. 8A, Product X) illustrating that the Ara5
acceptor was not extended via an EMB-sensitive a(1→5)
arabinofuranosyltransferase. Interestingly, membranes
prepared from the M. smegmatisDaftC strain were unable
to synthesize the in vitro product to the same level of
activity that was observed with wild-type membranes pre-
pared from M. smegmatis (Fig. 8A). This was to be
expected, as our earlier in vivo and in vitro studies would
have anticipated residual Ara6 product formation, consid-
ering that M. smegmatisDaftC possesses b(1→2) ara-
binofuranosyltransferase activity. Assays performed with
Fig. 5. GC analysis of cell walls of M. smegmatis,
M. smegmatisDaftC, M. smegmatisDaftC pMV261-Ms-aftC and
M. smegmatisDaftC pMV261-Mt-aftC. Samples of purified cell
walls were hydrolysed with 2 M TFA, reduced, per-O-acetylated
and analysed as described under Experimental procedures
(Besra et al., 1995; Alderwick et al., 2005).
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membranes from the M. smegmatisDaftC pMV261-Mt-
aftC complemented strain, gave a similar profile to that of
wild-type M. smegmatis (Fig. 8A).
To establish that theAra5 acceptor is being utilized by two
different arabinofuranosyltransferases, presumably estab-
lishing b(1→2) and a(1→3) linkages, assays similar to that
used before were scaled up (see Experimental proce-
dures) and product X extracted and purified through
preparative TLC for each membrane preparation. GC
(Sassaki et al., 2005) and GC/MS (Alderwick et al., 2005)
analyses of the partially per-O-methylated, per-O-
acetylated alditol acetate derivatives of product X in assays
performed with M. smegmatis membranes revealed the
addition of b(1→2) [Rt 11.75 min; m/z 129, 130,161,190]
and a(1→3) [Rt 12.39 min; m/z 118, 129, 130, 190, 202,
233] linked Araf residues (Fig. 9A and B). Therefore, the
product migrating below Ara5 and coincident with the Ara6
acceptor standard on TLC (Fig. 8A and B) is in fact a
mixture of two products (Fig. 9B). The addition of b(1→2)-
linked Araf residues can be attributed to the function of
AftB. The presence of a(1→3)-linked Araf residues in this
assay using an Ara5 acceptor clearly highlights the role of a
novel arabinofuranosyltransferase(s) capable of function-
ing in an a(1→3) capacity. Importantly, the level of a(1→3)
activity when the Ara5 acceptor is incubated with mem-
branes prepared from M. smegmatisDaftC is completely
abolished (Fig. 9A). However, b(1→2) activity is clearly
present in M. smegmatisDaftC (Fig. 9A). In addition,
M. smegmatisDaftC complemented with pMV261-Mt-aftC
restores a(1→3) arabinofuranosyltransferase activity to
wild-type M. smegmatis (Fig. 9A). The results clearly
establish both from in vivo and in vitro experiments that
AftC catalyses the addition of an a(1→3)-Araf unit via an
a(1→3) arabinofuranosyltransferase and that this enzyme
is also resistant to EMB (Fig. 8A).
Discussion
The mAGP complex represents one of the most important
cell wall components of the Corynebacterianeae and is
Fig. 6. GC/MS analysis of cell walls of M. smegmatis, M. smegmatisDaftC, M. smegmatisDaftC pMV261-Ms-aftC and M. smegmatisDaftC
pMV261-Mt-aftC. Samples of per-O-methylated cell walls were hydrolysed with 2 M TFA, reduced, per-O-acetylated and analysed as
described under Experimental procedures (Besra et al., 1995; Alderwick et al., 2005).
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essential for the viability of M. tuberculosis (Vilcheze
et al., 2000; Pan et al., 2001; Gande et al., 2004; Mills
et al., 2004). It is therefore not surprising that one of the
most effective antimycobacterial drugs, EMB, targets its
synthesis through inhibition of AG biosynthesis. However,
the emergence of MDR-TB and XDR-TB has accelerated
the need to discover new drug targets (Brennan and
Nikaido, 1995). One of the strategies is to identify genes
involved in AG biosynthesis. Based on this strategy we
previously identified the presence of a new ‘priming’
enzyme, now termed AftA, which would link the initial Araf
unit with the C-5 OH of a b(1→6) linked Galf of a pre-
synthesized galactan core (Alderwick et al., 2005), and
more recently identified the AftB enzyme responsible for
b(1→2) Araf residues.
The previously described Emb (Alderwick et al., 2005),
AftA (Alderwick et al., 2006a) and AftB proteins (Seidel
et al., 2007a) are distinct arabinofuranosyltransferases.
Thus, despite some functional relationship, these glyco-
syltransferases have inherent specific features as evident
from the insensitivity of AftA and AftB towards EMB,
whereas the single Cg-Emb (Alderwick et al., 2005; Rad-
macher et al., 2005) and Mt-Emb proteins are sensitive
towards EMB (Telenti et al., 1997; Belanger et al., 1996).
The number of arabinofuranosyltransferases that are
required for mycobacterial arabinan biosynthesis has
been a matter of speculation to date depending on how
the arabinan chains are assembled. The primary structure
of AG (Besra et al., 1995; Daffé et al., 1990) would
suggest at least five distinct arabinofuranosyltransferases
are required for the complete formation of AG. Interest-
ingly, M. smegmatis embA and embB mutants were found
to possess reduced amounts of the non-reducing terminal
disaccharide b-D-Araf-(1→2)-a-D-Araf and result in the
removal of the dominant terminal non-reducing Ara6
branched motif in the mutant being replaced by a linear
Ara4 motif (Escuyer et al., 2001). The authors of this study
concluded that the M. smegmatis embA and embB
mutants result in a lack of 3-arm branching off the main
a(1→5)-arabinan chain proximal to the non-reducing and
attachment site of mycolic acids in AG (Escuyer et al.,
2001). Initially, it was proposed that the b-D-Araf-(1→2)-
a-D-Araf disaccharide was assembled using EmbA and
EmbB. However, the recent identification of AftB, the
development of specific in vitro assays in combination
with mutant strains, and recent structural studies have
Fig. 7. Arabinofuranosyltransferase
activity utilizing an Ara2 acceptor and
membranes prepared from M. smegmatis,
M. smegmatisDaftC and M. smegmatisDaftC
pMV261-Mt-aftC.
A. Biosynthetic reaction scheme of products A
and B formed in arabinofuranosyltransferase
assays using the neoglycolipid Ara2 acceptor.
B. Arabinofuranosyltransferase activity was
determined using the synthetic Ara2 acceptor
in a cell-free assay with and without EMB
(1 mg ml-1) as previously described (Lee
et al., 1997). The products of the assay were
re-suspended prior to scintillation counting
(10%) and the remaining subjected to TLC
using silica gel plates (5735 silica gel 60F254,
Merck) in CHCl3/CH3OH/H2O/NH4OH
(65/25/3.6/0.5, v/v/v/v) with the reaction
products visualized by autoradiography. The
TLC autoradiogram is representative of
several independent experiments.
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fuelled speculation that EmbA/B act as a(1→5) arabino-
furanosyltransferases (Alderwick et al., 2005; Seidel
et al., 2007a; Bhamidi et al., 2008).
In this study, we have identified MSMEG2785 (also
Rv2673 and NCgl1822, which we have termed AftC, as a
novel branching arabinofuranosyltransferase. More pre-
cisely, AftC catalyses the addition of a(1→3) Araf residues
as shown through both in vivo and in vitro experiments,
ultimately resulting in 3,5-Araf residues after further
a(1→5) extension, characteristic of AG. For instance,
incubation of membranes prepared from M. smegmatis
with DP[14C]A and a linear a(1→5)-Ara5 neoglycolipid
acceptor resulted in the synthesis of an Ara6 product.
Further chemical characterization of the product by glyco-
syl linkage analysis established that the a(1→5)-Ara5
acceptor was extended via an EMB-resistant a(1→3) ara-
binofuranosyltransferase giving rise to 3-linked Araf resi-
dues and corroborated our earlier cell wall analysis of the
M. smegmatisDaftC mutant. As it is now established that
only a(1→5) arabinofuranosyltransferase(s) is EMB-
sensitive it can be further speculated that EmbA and
EmbB function in the assembly of the linear a(1→5) ara-
binan segments as presented in Fig. 10, which is in accor-
dance with previous data and the phenotype of a Cg-Emb
mutant (Alderwick et al., 2005). It is clear that further
studies are required to establish the precise role of EmbA
and EmbB in mycobacteria.
The analysis of the M. smegmatisDaftC mutant to date
and based on the Ara : Gal ratio would suggest that the
residual arabinan segment in the mutant consists of
approximately five Araf residues: b-D-Araf-(1→2)-a-D-
Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf
located at three branches on the galactan chain (Besra
et al., 1995; Alderwick et al., 2005). This is consistent with
the recent primary structure of AG (Bhamidi et al., 2008),
with a ‘non-variable’ terminal non-reducing Ara17 motif,
introduction of a 3,5-Araf residue distal to this non-
reducing end by AftC and further extension by a linear
a(1→5)Araf domain (Fig. 10). The latter appears to be
variable (up to 12/13 residues). However, based on
M. smegmatisDaftC and the subsequent Ara : Gal compo-
sitional analysis a dominant Ara22/Ara23 motif would be
consistent with recent (Bhamidi et al., 2008) and previous
(Besra et al., 1995) structural data on AG and this is
represented in terms of biosynthetic considerations in
Fig. 10. It is also possible that AftC or a second distinct
a(1→3) arabinosfuranosyltransferase (shown as AftD in
Fig. 10) may be involved in late stages of AG synthesis,
i.e. the non-reducing Ara6 motif and is consistent with our
data and the model presented in Fig. 10.
The discovery of AftC has now shed new light on the
key arabinofuranosyltransferases to build an arabinan
domain typical for Corynebacterianae. In this context, the
genomic organization in the genomes of the Corynebac-
terianae sequenced is intriguing, revealing high synteny
of the M. tuberculosis aftC locus to the maps of all other
Mycobacterium and Corynebacterium species. The iden-
tification of new cell wall biosynthetic drug targets is of
Fig. 8. Arabinofuranosyltransferase activity utilizing an Ara5 acceptor and membranes prepared from M. smegmatis, M. smegmatisDaftC and
M. smegmatisDaftC pMV261-Mt-aftC.
A. Arabinofuranosyltransferase activity was determined using the synthetic Ara5 acceptor in a cell-free assay with and without EMB
(1 mg ml-1). The products reflective of three independent enzyme preparations and assays were re-suspended prior to scintillation counting
(10%) and the remaining subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in isopropanol/acetic acid/water (8/1/1/,
v/v/v) with the reaction product X visualized by autoradiography. The TLC autoradiogram is representative of three independent experiments.
B. Ara5 and Ara6 (Appelmelk et al., 2008) acceptor standards were subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in
isopropanol/acetic acid/water (8/1/1/, v/v/v) with the reaction products visualized by staining with a-naphthol followed by charring.
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great importance, especially with the emergence of MDR-
TB. This newly discovered DPA-dependent arabinofura-
nosyl transferase represents, along with a straightforward
in vitro enzyme assay, a promising candidate for further
exploitation as a potential drug target.
Experimental procedures
Bacterial strains and growth conditions
Corynebacterium glutamicum ATCC 13 032 (referred to the
remainder of the text as C. glutamicum) and Escherichia
coli DH5amcr were grown in Luria–Bertani broth (LB, Difco)
at 30°C and 37°C respectively. The recombinant strains
generated in this study were grown on complex brain–heart
infusion medium (BHI, Difco), and the salt medium CGXII
used for C. glutamicum as described (Eggeling and Reyes,
2005). Kanamycin and ampicillin were used at a concentra-
tion of 50 mg ml-1. M. smegmatis strains were grown in
tryptic soy broth (TSB; Difco), containing 0.005% Tween80
(TSBT). Solid media were made by adding 1.5% agar to the
above-mentioned broths. The concentrations of antibiotics
used for M. smegmatis were 100 mg ml-1 for hygromycin
and 20 mg ml-1 for kanamycin. Minimal inhibitory concentra-
tions were determined by plating cells on solid media
supplemented with various concentrations of EMB, rifampi-
cin and chloramphenicol. The minimal inhibitory concentra-
tion was defined as the first concentration of drug that
would inhibit 100% of growth after 5 days of incubation
(Belanger et al., 1996). M. tuberculosis H37Rv DNA was
obtained from the NIH Tuberculosis Research Materials and
Vaccine Testing Contract at Colorado State University. All
other chemicals were of reagent grade and obtained from
Sigma-Aldrich.
Construction of plasmids and strains
Approximately 1 kb of upstream and downstream flanking
sequences of MSMEG2785 were PCR amplified from
Fig. 9. GC characterization of in vitro synthesized product X from the arabinofuranosyltransferase assays utilizing the Ara5 acceptor.
A. GC analysis of the partially per-O-methylated, per-O-acetylated alditol acetate derivative of product X obtained from assays containing
membranes prepared from either M. smegmatis, M. smegmatisDaftC or M. smegmatisDaftC pMV261-Mt-aftC (Sassaki et al., 2005).
B. Panel illustrates the structure(s) of product X.
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M. smegmatis mc2155 genomic DNA using the primer pairs
MS2785LL (TTTTTTTTCCATAAATTGGATCCGCTGACCG
ACCTCATC) and MS2785LR (TTTTTTTTCCATTTCTTGGC
GAGCCCGAGCTTGAAGTTG), and MS2785RL (TTTTT
TTTCCATAGATTGGTTCCTGCTGCTGTCCCTTGG) and
MS2785RR (TTTTTTTTCCATCTTTTGGCGAACTCAGC
GGCGATTCAC) respectively (all primers are given in 5′
to 3′ direction). Following restriction digestion of the primer
incorporated Van91I sites, the PCR fragments were
cloned into Van91I-digested p0004S to yield the knockout
plasmid pDMSMEG2785 which was then packaged into
the temperature-sensitive mycobacteriophage phAE159 as
described previously (Bardarov et al., 2002) to yield phasmid
DNA of the knockout phage phDMSMEG2785. Generation of
high titre phage particles and specialized transduction were
performed as described earlier (Stover et al., 1991; Bardarov
et al., 2002). Deletion of MSMEG2785 in one hygromycin-
resistant transductant was confirmed by Southern blot. To
enable expression of MSMEG2785 and Rv2673, in the dele-
tion mutant, these were amplified using primer pairs designed
for subsequent cloning into the mycobacterial-shuttle vector
pMV261 (Stover et al., 1991). All cloned fragments were veri-
fied by sequencing.
To construct the deletion vector pK19mobsacBDaftC (NCgl
1822), cross-over PCR was applied with primer pairs AB
(A, CGTTAAGCTTCGATCTTGTTGATGTGTGGCATCACA
CG; B, CCCATCCACTAAACTTAAACAGCGCCATCAACAA
CATGG) and CD (C, TGTTTAAGTTTAGTGGATGGGTGATC
CAACGCACGACCATC; D, GCATGGATCCACGCATACCG
AGGGAAAGATCTTC) and C. glutamicum genomic DNA as
template. Both amplified products were used in a second
PCR with primer pairs AD to generate a 656 bp fragment
consisting of sequences adjacent to Cg-aftC, which was
ligated with BamHI–HindIII-cleaved pK19mobsacB. All plas-
mids were confirmed by sequencing. The chromosomal dele-
tion of Cg-aftC was performed as described previously using
two rounds of positive selection (Schafer et al., 1994), and its
successful deletion was verified by use of two different primer
pairs.
Isolation of the mAGP complex, glycosyl composition
and linkage analysis of alditol acetates by GC and
GC/MS
The thawed cells were re-suspended in phosphate-buffered
saline containing 2% Triton X-100 (pH 7.2), disrupted by soni-
caton and centrifuged at 27 000 g (Besra et al., 1995; Alder-
wick et al., 2005). The pelleted material was extracted three
times with 2% SDS in phosphate-buffered saline at 95°C for
1 h, washed with water, 80% (v/v) acetone in water and
acetone, and finally lyophilized to yield a highly purified cell
wall preparation (Besra et al., 1995; Alderwick et al., 2005).
Cell wall or per-O-methylated cell wall preparations (Alder-
wick et al., 2005) were hydrolysed in 2 M TFA, reduced with
NaB2H4 and the resultant alditols per-O-acetylated and exam-
ined by GC and GC/MS as described previously (Besra et al.,
1995; Alderwick et al., 2005).
Extraction and analysis of cell wall-bound mycolic acids
In terms of M. smegmatis strains equivalent amounts of
freeze-dried bacilli (100 mg) were processed as described
Fig. 10. Mycobacterial arabinan biosynthesis and the role of AftC.
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previously (Seidel et al., 2007a), following two consecutive
CHCl3/CH3OH/H2O (10:10:3, v/v/v) extractions for 4 h at
50°C in the analysis of cell wall-associated lipids, and
cell wall-bound MAMEs. Alternatively, M. smegmatis and
C. glutamicum cultures (5 ml) were grown and metabolically
labelled at mid-logarithmic phase of growth using 1 mCi ml-1
[1,2-14C]acetate (50–62 mCi mmol-1, GE Healthcare, Amer-
sham Bioscience) for 4 h at either 30°C or 37°C with gentle
shaking, harvested, washed and freeze-dried. Cells were
then extracted by two consecutive extractions with 2 ml
of CHCl3/CH3OH/H2O (10:10:3, v/v/v) for 4 h at 50°C to
provide cell wall-associated lipids and analysed as
described previously (Seidel et al., 2007a). The crude lipid
extracts were re-suspended in CHCl3/CH3OH (2:1) and
equivalent aliquots (50 000 cpm) analysed by TLC using
silica gel plates (5735 silica gel 60F254, Merck) developed
in CHCl3/CH3OH/NH4OH (80:20:2, v/v/v) to separate [14C]-
labelled TDM and phospholipids (Mikusova et al., 1995).
Lipids were visualized by autoradiography by overnight
exposure of Kodak X-Omat AR film to the TLC plates to
reveal labelled lipids, quantified by phosphorimaging and
compared with know standards (Mikusova et al., 1995).
The bound MAMEs/CMAMEs from the above de-lipidated
extracts were released by the addition of 2 ml of 5%
aqueous solution of tetra-butyl ammonium hydroxide fol-
lowed by overnight incubation at 100°C. After cooling, water
(2 ml), CH2Cl2 (4 ml) and CH3I (500 ml) were added and
mixed thoroughly for 30 min. The lower organic phase was
recovered following centrifugation and washed three times
with water (4 ml), dried and re-suspended in diethyl ether
(4 ml). After centrifugation the clear supernatant was again
dried and re-suspended in CH2Cl2 (100 ml). An aliquot (5 ml)
from each strain was subjected to scintillation counting and
an equivalent (5 ml) aliquot analysed by TLC using silica gel
plates (5735 silica gel 60F254, Merck), developed in petro-
leum ether/acetone (95:5, v/v) and either visualized by auto-
radiography by exposure of Kodak X-Omat AR film to the
TLC plates to reveal [14C]-labelled MAMEs/CMAMEs, or
charred following spraying with 5% molybdophosphoric acid
in ethanol at 100°C and compared with know standards.
Arabinofuranosyltransferase activity with membrane
preparations of M. smegmatis, M. smegmatis
pMV261-Mt-aftC, M. smegmatisDaftC and
M. smegmatisDaftC pMV261-Mt-aftC
Membranes were prepared as described previously (Lee
et al., 1997; Alderwick et al., 2006a) and re-suspended in
50 mM MOPS (pH 7.9), containing 5 mM b-mercaptoethanol
and 10 mM MgCl2 (buffer A) to a final concentration
of 15–10 mg ml-1. The neoglycolipid acceptors used in
this study were a-D-Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-
(1→5)-a-D-Araf-(1→5)-a-D-Araf-O-(CH2)8NH2 (Ara5, see Sup-
plementary material) and a-D-Araf-(1→5)-a-D-Araf-O-
(CH2)7CH3 (Ara2) (Lee et al., 1995; 1998). The acceptors
(either Ara2 or Ara5) and DP[14C]A (Lee et al., 1995; 1998)
(stored in CHCl3/CH3OH, 2:1, v/v) were aliquoted into 1.5 ml
eppendorf tubes to a final concentration of 2 mM and
200 000 cpm (90 mM), respectively, and dried under nitro-
gen. The arabinofuranosyltransferase assay was carried out
as described previously (Lee et al., 1997) with modifica-
tions. IgePalTM (Sigma-Aldrich) was added (0.1%, v/v) with
the appropriate amount of buffer A (final volume 80 ml).
Tubes were sonicated for 15 min to re-suspend lipid linked
substrates and then mixed with the remaining assay
components, which included membrane protein from
either M. smegmatis, M. smegmatis pMV261-Mt-aftC
M. smegmatisDaftC or M. smegmatisDaftC pMV261-Mt-aftC
(1 mg), 1 mM ATP, 1 mM NADP and in some cases EMB
(0–1 mg ml-1). Assays were incubated for 1 h at 37°C and
quenched by the addition of 533 ml CHCl3/CH3OH (1:1, v/v).
After mixing and centrifugation at 27 000 g for 15 min at
4°C, the supernatant was removed and dried under nitro-
gen. The residue was then re-suspended in 700 ml of
CH3CH2OH/H2O (1:1, v/v) and loaded onto a 1 ml SepPak
strong anion exchange cartridge (Supelco), pre-equilibrated
with CH3CH2OH/H2O (1:1, v/v). The column was washed
with 2 ml CH3CH2OH and the eluate collected, dried and
partitioned between the two phases arising from a mixture
of n-butanol (3 ml) and water (3 ml). The resulting organic
phase was recovered following centrifugation at 3500 g and
the aqueous phase again extracted twice with 3 ml of water-
saturated n-butanol. The pooled extracts were back-washed
twice with n-butanol-saturated water (3 ml). The n-butanol
fraction was dried and re-suspended in 200 ml butanol. The
extracted radiolabelled material was quantified by liquid
scintillation counting using 10% of the labelled material and
5 ml of EcoScintA (National Diagnostics, Atlanta). The incor-
poration of [14C]Araf was determined by subtracting counts
present in control assays (incubations in the absence of
acceptor). The remaining labelled material was subjected to
thin-layer chromatography (TLC) using either isopropanol/
acetic acid/water (8:1:1, v/v/v) for the assays utilizing the
Ara5 acceptor or CHCl3/CH2OH/H2O/NH4OH (65:25:3.6:0.5,
v/v/v/v) in the case of the Ara2 acceptor on aluminum-
backed Silica Gel 60 F254 plates (Merck, Darmstadt,
Germany). Autoradiograms were obtained by exposing
TLCs to X-ray film (Kodak X-Omat) for 3 days.
Characterization of a(1,3)-arabinofuranosyltransferase
activity with membranes prepared from M. smegmatis,
M. smegmatisDaftC and M. smegmatisDaftC
pMV261-Mt-aftC
Large-scale reaction mixtures containing cold DPA (200 mg,
0.75 mM) (Lee et al., 1997) and 50 mM of the acceptor Ara5
were mixed and given an initial incubation at 37°C with
membranes prepared from either M. smegmatis, M. smeg-
matisDaftC or M. smegmatisDaftC pMV261-Mt-aftC for 1 h.
The assays were replenished with fresh membranes (1 mg)
and re-incubated for 1 h at 37°C with the entire process
repeated thrice. Products were extracted from reaction mix-
tures by n-butanol/water phase separation as described
earlier to extract products. Products were applied to pre-
parative TLC plates, developed in isopropanol/acetic
acid/water (8:1:1, v/v/v) and sprayed with 0.01% 1,6-
diphenylhexatriene in petroleum-ether/acetone (9:1, v/v),
and the products localized under long-wave (366 nm) UV
light (Lee et al., 1997). The plate was then re-developed in
toluene to remove the reagent and the bands recovered
from the plates by extraction with n-butanol. The butanol
phases were washed with water saturated with n-butanol
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and the dried products subjected to GC (Sassaki et al.,
2005) and GC/MS as described (Lee et al., 1997; Alderwick
et al., 2006a).
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